Colleagues and staff from the University of Arizona, other universities and industry groups he’s worked with join John Galgiani, MD, an infectious diseases professor and Valley Fever Center for Excellence founding director, to celebrate his winning the 2023 Pioneer Award for Lifetime Achievement from the Arizona Bioindustry Association at a ceremony at the Phoenix Convention Center.
Congratulations to John N. Galgiani, MD (center in above photo), professor of medicine in the Division of Infectious Diseases at the University of Arizona College of Medicine – Tucson and Phoenix and founding director of the Valley Fever Center for Excellence.
As announced in August, he was presented on the evening of Sept. 27 with the Arizona Bioindustry Association’s AZBio Pioneer Award for Lifetime Achievement at the awards ceremony that culminates Arizona BioScience Week, this year held Sept. 25-29 with a series of events in the Phoenix area.
The ceremony and dinner were at the Phoenix Convention Center.
“It is such an honor to have been selected by AzBio for its Pioneer Award and to be on the same list as the UA Cancer Center’s Dr. David Alberts, the UA Health Sciences’ and C-Path’s Dr. Ray Woosley, the UA Center for Accelerated Biomedical Innovation’s and Sarver Heart Center’s Dr. Marvin Slepian, and UA Pathology’s and Ventana Medical Systems’ Dr. Tom Grogan – all previous winners of this honor,” said Dr. Galgiani.
“More than anything else, I feel this highlights the emerging realization that Valley fever is a major public health problem for Arizona and other western states, it needs to be managed, and the Valley Fever Center for Excellence is providing the leadership to do that.”
The day following the awards ceremony, Dr. Galgiani – who joined the UArizona faculty in 1978 after a fellowship at Stanford University where he began studying Coccidioidomycosis, the infection that causes Valley fever, two years earlier – participated in a “Innovation & Man’s Best Friend” panel discussion on vaccine development to protect against the deadly fungal disease. He established the Valley Fever Center in 1996 with the backing of the Arizona Board of Regents.
Anivive Lifesciences, which licensed a vaccine in 2017 developed by the center’s research team from the UArizona’s commercialization arm Tech Launch Arizona, is poised to bring the first fungal vaccine to market for any species – in this case to protect dogs against Valley fever – soon.
More recently Dr. Galgiani helped launch the Valley Fever Collaborative, an alliance of the state’s three public universities and industry that was created in 2021 to tackle this illness caused by inhaling Coccidioides spores found in arid soils of the U.S. Southwest in a more comprehensive way. That includes advancing a vaccine for humans. About two thirds of Cocci infections occur in Arizona.
You can view the video used to highlight milestones in Dr. Galgiani’s career at this link.
Mouseover the images for captions and click on them to enlarge.
“Paving a path for Valley fever research, treatment, prevention” | Posted Oct. 1, 2023
“UArizona Valley fever expert, Dr. Galgiani to receive lifetime achievement award” | Posted Aug. 18, 2023
"Urgent Care data show Valley fever season has begun in Arizona" | Posted July 27, 2023
"Study Finds Valley Fever Training Improves Early Recognition of the Disease" | Posted Feb. 1, 2023